METHOD FOR THE IN VITRO DIAGNOSIS OF PANCREATIC DUCTAL ADENOCARCINOMA OR FOR DETERMINING THE PREDISPOSITION TO PANCREATIC DUCTAL ADENOCARCINOMA

摘要

An in vitro assay for pancreatic ductal adenocarcinoma, preferably an immunoassay, is based on the determination of anti-ezrin auto-antibodies in a biological sample from a subject suspected of being affected by pancreatic ductal adenocarcinoma or from a subject whose predisposition to pancreatic ductal adenocarcinoma one desires a determination.